Zargar Fatemeh, Rahafrouz Leila, Tarrahi Mohammad Javad
Department of Health Psychology, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2021 Feb 26;10:9. doi: 10.4103/abr.abr_111_19. eCollection 2021.
Patients with somatic symptom disorder (SSD) had a poor quality of life and suffered from depression, anxiety, and stress. Mindfulness-based stress reduction (MBSR) is a psychological treatment with remarkable effects on several psychological disorders. This study aimed to evaluate the effect of the MBSR program on psychological symptoms, quality of life, and symptom severity in patients with SSD.
The patients with SSD were randomly divided into two groups of receiving venlafaxine alone and venlafaxine with an 8-week MBSR program. Depression, anxiety, and stress with their severities were assessed along with the quality of life, the number of physical symptoms and their severities, as well as SSD severity before and after the intervention. Subsequently, the results were compared between the two groups.
This study included 37 patients with SSD who referred to Shariati Psychosomatic Clinic, Isfahan, Iran, with a mean age of 37.08 ± 8.26 years. It should be noted that 37.8% of the participants were male. The intervention group obtained significantly lower scores in depression, anxiety, stress, and their severities, compared to the control group. Moreover, the number of physical symptoms, their severity, and the severity of SSD were significantly decreased more in the intervention group rather than the controls.
The MBSR accompanied by prescribing venlafaxine can significantly reduce the severity of SSD, as well as the number and severity of physical symptoms. Moreover, it can reduce depression, anxiety, stress, and their severity. The MBSR can be used as complementary medicine for the treatment of patients with SSD.
躯体症状障碍(SSD)患者生活质量较差,且患有抑郁症、焦虑症和压力相关问题。基于正念的减压疗法(MBSR)是一种对多种心理障碍有显著疗效的心理治疗方法。本研究旨在评估MBSR项目对SSD患者心理症状、生活质量和症状严重程度的影响。
将SSD患者随机分为两组,一组仅接受文拉法辛治疗,另一组接受文拉法辛联合为期8周的MBSR项目治疗。在干预前后,评估患者的抑郁、焦虑和压力及其严重程度,同时评估生活质量、躯体症状数量及其严重程度以及SSD严重程度。随后,比较两组结果。
本研究纳入了37例转诊至伊朗伊斯法罕沙里亚蒂身心诊所的SSD患者,平均年龄为37.08±8.26岁。需要注意的是,37.8%的参与者为男性。与对照组相比,干预组在抑郁、焦虑、压力及其严重程度方面的得分显著更低。此外,干预组的躯体症状数量、严重程度以及SSD严重程度的下降幅度明显大于对照组。
文拉法辛联合MBSR可显著降低SSD的严重程度以及躯体症状的数量和严重程度。此外,还可减轻抑郁、焦虑、压力及其严重程度。MBSR可作为治疗SSD患者的辅助药物。